Clincosm LogoSign in Get a demo

Relapsing Multiple Sclerosis

Showing 26 - 50 of 62
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsing Multiple Sclerosis Trial in Puerto Rico, United States (Ofatumumab)

Recruiting
  • Relapsing Multiple Sclerosis
  • Birmingham, Alabama
  • +16 more
Mar 22, 2022

Relapsing Multiple Sclerosis Trial in Worldwide (Laquinimod)

Terminated
Has Results
  • Relapsing Multiple Sclerosis
  • Homewood, Alabama
  • +143 more
Dec 7, 2021

Relapsing Multiple Sclerosis Trial in Worldwide (Laquinimod)

Terminated
Has Results
  • Relapsing Multiple Sclerosis
  • Phoenix, Arizona
  • +134 more
Dec 7, 2021

Relapsing Multiple Sclerosis Trial in United States (Fingolimod)

Completed
Has Results
  • Relapsing Multiple Sclerosis
  • Birmingham, Alabama
  • +65 more
Oct 6, 2021

Relapsing Multiple Sclerosis Trial in Worldwide (Ofatumumab subcutaneous injection, Teriflunomide-matching capsules,

Completed
Has Results
  • Relapsing Multiple Sclerosis
  • Ofatumumab subcutaneous injection
  • +3 more
  • Phoenix, Arizona
  • +165 more
Sep 3, 2021

Relapsing Multiple Sclerosis Trial in Atlanta (Ocrelizumab, Platform)

Recruiting
  • Relapsing Multiple Sclerosis
  • Atlanta, Georgia
  • +1 more
Sep 14, 2021

Relapsing Multiple Sclerosis Trial in United States (Quadrivalent influenza vaccine, Ofatumumab)

Recruiting
  • Relapsing Multiple Sclerosis
  • Phoenix, Arizona
  • +3 more
Aug 30, 2021

Relapsing Multiple Sclerosis Trial in Boston (Ofatumumab, [F-18]PBR06)

Recruiting
  • Relapsing Multiple Sclerosis
  • Boston, Massachusetts
    Partners MS Center, 60 Fenwood Road
Jul 20, 2021

Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Relapsing Multiple Sclerosis Trial in Boston

Recruiting
  • Primary Progressive Multiple Sclerosis
  • +3 more
  • Boston, Massachusetts
    Brigham and Women's Hospital
Jul 20, 2021

Relapsing Multiple Sclerosis Trial in Worldwide (Tolebrutinib, Teriflunomide HMR1726, Placebo to match Tolebrutinib)

Recruiting
  • Relapsing Multiple Sclerosis
  • Beijin, China
    Peking University Third Hospital
Jul 6, 2021

Cinnomer® in Multiple Sclerosis Treatment in Iran

Completed
  • Relapsing Multiple Sclerosis
  • Glatiramer Acetate
  • (no location specified)
Jun 13, 2021

Relapsing Multiple Sclerosis Trial (Placebo, BIIB061, Interferon-beta1)

Not yet recruiting
  • Relapsing Multiple Sclerosis
  • Placebo
  • +3 more
  • (no location specified)
Mar 22, 2021

Relapsing Multiple Sclerosis Trial in Worldwide (Ozanimod, Ozanimod , Interferon beta-1a)

Completed
Has Results
  • Relapsing Multiple Sclerosis
  • Phoenix, Arizona
  • +298 more
Jan 25, 2021

Relapsing Multiple Sclerosis Trial in Worldwide (Ozanimod, Placebo)

Completed
Has Results
  • Relapsing Multiple Sclerosis
  • Berkeley, California
  • +57 more
Jan 25, 2021

Relapsing Multiple Sclerosis Trial in Worldwide (SAR442168, Placebo, Locally approved intravenous contrast medium for contrast

Completed
  • Relapsing Multiple Sclerosis
  • Cullman, Alabama
  • +47 more
Jan 19, 2021

Autoimmune Diseases, Relapsing Multiple Sclerosis Trial in London (Fecal microbiota)

Terminated
Has Results
  • Autoimmune Diseases
  • Relapsing Multiple Sclerosis
  • Fecal microbiota
  • London, Ontario, Canada
    London Health Sciences Centre, University Hospital
Nov 12, 2019

ADA SNPs in Subjects With Relapsing Multiple Sclerosis (RMS)

Not yet recruiting
  • Relapsing Multiple Sclerosis
  • Blood withdrawal
  • Pozzilli, Isernia, Italy
    IRCCS Neuromed
Oct 7, 2019

Relapsing Multiple Sclerosis, Clinically Isolated Syndrome Trial in Darmstadt (Rebif)

Completed
Has Results
  • Relapsing Multiple Sclerosis
  • Clinically Isolated Syndrome
  • Darmstadt, Germany
    Please contact the Merck KGaA Communication Center
Mar 29, 2018

Relapsing Multiple Sclerosis Trial in United States (natalizumab)

Terminated
Has Results
  • Relapsing Multiple Sclerosis
  • Fullerton, California
  • +10 more
Apr 24, 2017

Relapsing Multiple Sclerosis Trial in Worldwide (Atacicept 25 mg, Atacicept 75 mg, Atacicept 150 mg)

Terminated
Has Results
  • Relapsing Multiple Sclerosis
  • Atacicept 25 mg
  • +2 more
  • Phoenix, Arizona
  • +47 more
Feb 12, 2017

Relapsing Multiple Sclerosis Trial in Worldwide (FTY720)

Completed
  • Relapsing Multiple Sclerosis
  • Box Hill, Australia
  • +289 more
Feb 21, 2017

Relapsing Multiple Sclerosis Trial in United States (BIIB017, naproxen)

Completed
Has Results
  • Relapsing Multiple Sclerosis
  • Gilbert, Arizona
  • +37 more
Nov 30, 2016

Relapsing Multiple Sclerosis Trial in Worldwide (peginterferon beta-1a)

Completed
Has Results
  • Relapsing Multiple Sclerosis
  • peginterferon beta-1a
  • Atlanta, Georgia
  • +150 more
Nov 17, 2016

Relapsing Multiple Sclerosis Trial in Leuven, Liege (natalizumab)

Terminated
  • Relapsing Multiple Sclerosis
  • Leuven, Belgium
  • +1 more
Sep 27, 2016

Relapsing Forms of MS Receiving Treatment With Natalizumab

Completed
  • Relapsing Multiple Sclerosis
  • Birmingham, Alabama
  • +477 more
Sep 27, 2016